The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

The hypothesis was tested that the systemic immune milieu in recent-onset type 1 diabetes is associated with residual beta cell function and other metabolic patient characteristics.All patients (n = 89, 40% female) of the Diabetes and Atorvastatin (DIATOR) Trial were analyzed at recruitment, i.e. pr...

Full description

Bibliographic Details
Main Authors: Hubert Kolb, Kathrin Lückemeyer, Tim Heise, Christian Herder, Nanette C Schloot, Wolfgang Koenig, Lutz Heinemann, Stephan Martin, DIATOR Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3753272?pdf=render

Internet

http://europepmc.org/articles/PMC3753272?pdf=render

Similar Items